TRAILBLAZER‐ALZ Study: Dynamics of amyloid reduction after donanemab treatment

Authors :: Sergey Shcherbinin
Scott W. Andersen
Cynthia Duggan Evans
Albert C. Lo
Ming Lu
Michael Navitsky
Emily C Collins
John R. Sims
Dawn A. Brooks
Mark A Mintun
Source :: Alzheimer's & Dementia. 17
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Epidemiology
Health Policy
Neurology (clinical)
Geriatrics and Gerontology

Full Text Access

Tools